In addition, we found that ovarian carcinomas with loss of BRCA1 through genetic events and those with BRCA1 loss through epigenetic events both have activation of the PI3K/AKT pathway, though the mechanism of activation is different. Here, AKT1 is linked to ovarian carcinoma.